Vincent Doré

Government of the Commonwealth of Australia - CSIRO Health & Biosecurity

SCHOLARLY PAPERS

2

DOWNLOADS

464

TOTAL CITATIONS

5

Scholarly Papers (2)

1.

When Does Alzheimer's Disease Start? Robust Estimates Based on Longitudinal Aβ-Amyloid-PET in Three Large International Cohorts

Number of pages: 38 Posted: 18 Mar 2024
Government of the Commonwealth of Australia - CSIRO Health & Biosecurity, Government of the Commonwealth of Australia - CSIRO Health & Biosecurity, Washington University in St. Louis - Department of Radiology, Government of the Commonwealth of Australia - CSIRO (Commonwealth Scientific and Industrial Research Organisation), Washington University in St. Louis - Knight Alzheimer Disease Research Center, Edith Cowan University, Government of the Commonwealth of Australia - CSIRO Health & Biosecurity, University of Melbourne - Florey Institute of Neuroscience and Mental Health, Washington University Pediatric MS and other Demyelinating Disease Center, University of Melbourne - Florey Institute of Neuroscience and Mental Health, Edith Cowan University, Washington University in St. Louis - School of Medicine, Monash University, University of Melbourne - Melbourne Brain Centre, Edith Cowan University, Indiana University Purdue University Indianapolis (IUPUI) - Center for Neuroimaging, Government of the Commonwealth of Australia - CSIRO Health & Biosecurity, Murdoch University, Mayo Clinic, University of California, San Francisco (UCSF) - Department of Radiology and Biomedical Imaging, Australian eHealth Research Centre, CSIRO, Austin Health - Department of Molecular Imaging & Therapy, Washington University in St. Louis - Department of Radiology, University of California, San Francisco (UCSF) - Department of Neurology, University of Melbourne - Florey Institute of Neuroscience and Mental Health and Austin Health - Department of Molecular Imaging & Therapy
Downloads 300 (221,469)
Citation 5

Abstract:

Loading...

Aβ-amyloid, PET centiloid, Alzheimer's disease, Longitudinal cohorts, Prevention trials, Natural history

2.

Accurate Detection and Staging of Alzheimer's Disease by Plasma pTau217 on a High Throughput Immunoassay Platform

Number of pages: 26 Posted: 28 Mar 2024
University of Melbourne, Edith Cowan University, Government of the Commonwealth of Australia - CSIRO Health & Biosecurity, Austin Health, Austin Health, Government of the Commonwealth of Australia - CSIRO (Commonwealth Scientific and Industrial Research Organisation), Edith Cowan University, University of Melbourne - Florey Institute of Neuroscience and Mental Health, University of Melbourne - Florey Institute of Neuroscience and Mental Health, University of Melbourne - Florey Institute of Neuroscience and Mental Health, University of Melbourne - Melbourne Dementia Research Centre, Australian Alzheimer’s Research Foundation, Australian Alzheimer’s Research Foundation, Australian Alzheimer’s Research Foundation, University of Melbourne - Florey Institute of Neuroscience and Mental Health, AbbVie Inc., AbbVie Inc., University of Melbourne - Florey Institute of Neuroscience and Mental Health, Australian eHealth Research Centre, CSIRO, Austin Health - Department of Molecular Imaging & Therapy and Austin Health - Department of Molecular Imaging & Therapy
Downloads 164 (396,486)

Abstract:

Loading...

Alzheimer's Disease, dementia, Positron Emission Tomography, PET, MK6240, Tau, NAV4694, Aβ, plasma phospho-tau, phospho-tau 217, pTau217